Your Health, We Care
Immunomodulators are often used in the treatment of myeloma, which may lead to decreased immune function and neurotoxicity.
The use of these drugs requires close monitoring of the patient's immune function and neurological status, and prophylactic use of antiviral drugs, noting the possibility of secondary infection.
Corticosteroids such as dexamethasone and prednisone are widely used in myeloma treatment, but they can cause side effects such as elevated blood sugar, secondary infections, tuberculosis activity, and osteoporosis.
When using glucocorticoids, patients need to be regularly monitored for blood glucose levels, infection, tuberculosis activity, and bone health, and take appropriate measures to manage these side effects.
When using chemotherapy drugs, it is necessary to closely monitor the patient's gastrointestinal symptoms and hematological indicators, and take corresponding symptomatic measures, such as antiemetic and whitening.
Patients with myeloma may need to take multiple drugs at the same time, and it is necessary to be aware of drug interactions and contraindications.
